Can Zosyn (piperacillin/tazobactam) cause an elevation in creatinine levels without a corresponding increase in Blood Urea Nitrogen (BUN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

Renal: Elevations of creatinine or BUN, renal failure and interstitial nephritis have been reported The FDA drug label does not answer the question.

From the Research

Yes, Zosyn (piperacillin/tazobactam) can cause an elevation in creatinine levels without a corresponding increase in Blood Urea Nitrogen (BUN). This phenomenon is well-documented and is typically transient in nature. The elevation in creatinine is not usually indicative of actual kidney injury but rather results from interference with tubular secretion of creatinine. Piperacillin competes with creatinine for secretion at the organic anion transporters in the proximal tubule, leading to decreased creatinine elimination and subsequent elevation in serum levels 1. This effect is generally reversible upon discontinuation of the medication. Importantly, this represents a laboratory artifact rather than true kidney dysfunction, which is why BUN levels typically remain unchanged.

Key Points to Consider

  • The mechanism of piperacillin/tazobactam-induced nephrotoxicity involves direct tubular damage, oxidative stress, and mitochondrial damage in the kidney tubular cells 1.
  • Healthcare providers should be aware of this effect when monitoring renal function in patients receiving Zosyn, particularly when making clinical decisions based on creatinine values.
  • In most cases, the creatinine elevation resolves within a few days after stopping the antibiotic.
  • The most recent study 1 suggests that piperacillin/tazobactam can cause direct nephrotoxicity, which is associated with oxidative stress and mitochondrial damage in the kidney tubular cells.

Clinical Implications

  • Clinicians should exercise caution when prescribing piperacillin/tazobactam, especially in patients with pre-existing renal impairment or those at high risk of acute kidney injury.
  • Monitoring of renal function, including serum creatinine and BUN levels, is essential during piperacillin/tazobactam therapy.
  • The development of acute kidney injury during piperacillin/tazobactam therapy may require dose adjustment or discontinuation of the medication.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.